Human CD26/DPP4 PicoKine® Quick ELISA Kit | Boster FEK0696 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Boster

product type :

ELISA/assay

product name :

Human CD26/DPP4 PicoKine® Quick ELISA Kit

catalog :

FEK0696

quantity :

96 wells/kit, with removable strips.

product information

SKU :

FEK0696

Product Name :

Human CD26/DPP4 PicoKine® Quick ELISA Kit

Size :

96 wells/kit, with removable strips.

Description :

Human CD26/DPP4 PicoKine® Quick ELISA Kit (90 minutes, 96 Tests). Quantitate Human CD26/DPP4 in cell culture supernatants, serum, plasma (heparin, EDTA), saliva and urine. Sensitivity: 10 pg/ml.

Reactivity :

Human

Application :

ELISA

Gene Name :

DPP4

Uniprot ID :

P27487

Immunogen :

Expression system for standard: NS0; Immunogen sequence: D34-P766

Cross-reactivity :

There is no detectable cross-reactivity with other relevant proteins.

Assay Range :

312 pg/ml - 20,000 pg/ml

Sensitivity :

<10 pg/ml

Sample Type :

cell culture supernatants, serum, plasma (heparin, EDTA), saliva and urine

Capture/Detection Antibodies :

polyclonal antibody from goat, polyclonal antibody from goat

Storage :

Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Ships with gel ice, can store for up to 3 days in room temperature. Freeze upon receiving.)

Background :

Dipeptidyl peptidase-4(DPP4), also known as adenosine deaminase complexing protein 2 or CD26(cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene. By fluorescence in situ hybridization, the CD26 gene was mapped to 2q24.3. DPP4 plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. Furthermore, it appears to work as a suppressor in the development of cancer and tumours. CD26/ DPP4 plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others.